In Vitro Activity and In Vivo Efficacy of Anidulafungin in Murine Infections by Aspergillus flavus
- 1 March 2011
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (3) , 1290-1292
- https://doi.org/10.1128/aac.01282-10
Abstract
Anidulafungin (AFG) showed high activity against 27 strains of Aspergillus flavus by use of broth microdilution and disk diffusion methods. This drug was effective in vivo in a murine model of disseminated infection with five isolates tested. AFG was able to prolong survival and reduce tissue burden of infected mice but not able to reduce galactomannan serum concentrations. The AFG serum levels were above the corresponding minimum effective concentrations (MEC) for all of the strains tested.Keywords
This publication has 17 references indexed in Scilit:
- Correlation of In Vitro Activity, Serum Levels, and In Vivo Efficacy of Posaconazole against Rhizopus microsporus in a Murine Disseminated InfectionAntimicrobial Agents and Chemotherapy, 2009
- Aspergillus flavus: human pathogen, allergen and mycotoxin producerMicrobiology, 2007
- Efficacy of amphotericin B or amphotericin B–intralipid in combination with caspofungin against experimental aspergillosisJournal of Infection, 2006
- Paradoxical Increase in CirculatingAspergillusAntigen during Treatment with Caspofungin in a Patient with Pulmonary AspergillosisClinical Infectious Diseases, 2006
- Reviews Of Anti‐infective Agents: Anidulafungin: A Novel EchinocandinClinical Infectious Diseases, 2006
- Antifúngicos sistémicos. Farmacodinamia y farmacocinéticaRevista Iberoamericana de Micologia, 2006
- Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance programMedical Mycology, 2005
- Efficacies of Two New Antifungal Agents, the Triazole Ravuconazole and the Echinocandin LY-303366, in an Experimental Model of Invasive AspergillosisAntimicrobial Agents and Chemotherapy, 2000
- Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic RabbitsAntimicrobial Agents and Chemotherapy, 1998
- Efficacy of LY303366 against Amphotericin B-Susceptible and -Resistant Aspergillus fumigatus in a Murine Model of Invasive AspergillosisAntimicrobial Agents and Chemotherapy, 1998